Skip to main navigation Skip to search Skip to main content

Graves' Disease Mechanisms: The Role of Stimulating, Blocking, and Cleavage Region TSH Receptor Antibodies

Research output: Contribution to journalArticlepeer-review

130 Scopus citations

Abstract

The immunologic processes involved in Graves' disease (GD) have one unique characteristic - the autoantibodies to the TSH receptor (TSHR) - which have both linear and conformational epitopes. Three types of TSHR antibodies (stimulating, blocking, and cleavage) with different functional capabilities have been described in GD patients, which induce different signaling effects varying from thyroid cell proliferation to thyroid cell death. The establishment of animal models of GD by TSHR antibody transfer or by immunization with TSHR antigen has confirmed its pathogenic role and, therefore, GD is the result of a breakdown in TSHR tolerance. Here we review some of the characteristics of TSHR antibodies with a special emphasis on new developments in our understanding of what were previously called neutral antibodies and which we now characterize as autoantibodies to the cleavage region of the TSHR ectodomain.

Original languageEnglish
Pages (from-to)727-734
Number of pages8
JournalHormone and Metabolic Research
Volume47
Issue number10
DOIs
StatePublished - 14 Sep 2015

Keywords

  • Graves' disease
  • TSH
  • TSH-receptor antibodies
  • signaling
  • thyroid

Fingerprint

Dive into the research topics of 'Graves' Disease Mechanisms: The Role of Stimulating, Blocking, and Cleavage Region TSH Receptor Antibodies'. Together they form a unique fingerprint.

Cite this